ReviewAnnals of surgery2021

Neoadjuvant Therapy for Resectable Pancreatic Cancer: A New Standard of Care. Pooled Data From 3 Randomized Controlled Trials.

Dominique L Birrer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.